Premier Primary Evaluation Measuring Improved Efficacy of Rituximab With Sargramostim
Trademark details
Premier Primary Evaluation Measuring Improved Efficacy of Rituximab With Sargramostim® is a registered trademark used for Educational Services, Namely, Providing Classes, Seminars and Workshops In the Field of Crohn'S Disease Medical and Scientific Research Services and Conducting Studies In the Field of Crohn'S Disease Medical Services For Crohn'S Disease and owned by Bayer Schering Pharma Aktiengesellschaft. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Educational Services, Namely, Providing Classes, Seminars and Workshops In the Field of Crohn'S Disease Medical and Scientific Research Services and Conducting Studies In the Field of Crohn'S Disease Medical Services For Crohn'S Disease |
| Serial Number: | 78899541 |
| Filing Date: | Jun 2, 2006 |
|
Last Applicant(s)/ Owner(s) of Record | Bayer Schering Pharma AktiengesellschaftMullerstrasse 178 |
| Related Products: | Education and Entertainment, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services, Medical services; Veterinary services; Hygienic and beauty care for humans or animals |
Web Sites
powered by 
Total : 27,500 View more »
Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic ...
Rituximab Plus Sargramostim (GM-CSF) In Patients With ... factor (GM-CSF) together with rituximab can improve ... Final data collection date for primary outcome measure)
Management of inadequate response to TNF-α antagonist therapy in ...
Several tools are available that measure ... Rheumatology; REFLEX=Randomized Evaluation oF Long-term Efficacy of rituXimab ... phase III trial evaluating primary efficacy and ...
Arthritis Research & Therapy | Full text | Treatment options in ...
... study (Randomised Evaluation oF Long-term Efficacy of rituXimab ... courses of rituximab yielded sustained or improved efficacy compared ... trial evaluating primary efficacy ...
Treatment options in patients with rheumatoid arthritis failing ...
... Randomised Evaluation oF Long-term Efficacy of rituXimab in ... courses of rituximab yielded sustained or improved efficacy ... evaluating primary efficacy and ...
